Projects

• Client Syndax Pharmaceuticals (USA)

  Licensing of patent rights relating to international project on distribution of medicine in Russia, Ukraine and CIS states

  The activities of the company Syndax Pharmaceuticals (USA) is aimed at implementing strategies for the application of epigenetic therapies targeted at solving the problem of resistance of solid tumors. The company Syndax Pharmaceuticals acquired the exclusive rights to use the patented pharmaceutical composition “entinostat”. This medicine is a high-selective inhibitor of histone deacetylase (HDAC) for the treatment of breast and lung cancer.

  Read more

• Client IMS Software Services Ltd. (USA)

  Advising the company on acquisition of exclusive rights to trademarks, software, databases and other IP assets

  The American software company, which specializes in information technologies, decided to enter the Russian market and the CIS market through the acquisition of intangible assets of a well-known Russian company. The acquisition of assets was agreed between the companies, and the company addressed us as to the experts in the field of intellectual property and information technologies in order to verify the quality and sustainability of the acquired intangible assets, as well as to comply with the legislation of the relevant countries in the area of the transfer of the acquired rights to intellectual property rights.

  Read more

• Client Prysmian Cavi e Sistemi Energia S.r.l. (Italy)

  Licensing of the unique patented technologies, protected know-how subject matters and registered trademarks

  Prysmian Cavi e Sistemi Energia S.r.l. (Prysmian) specializes in the production of power cables, their components and related accessories. With the aim of investing in the development of its business in Russia, the company decided to offer a license of the unique patented technologies, protected objects of know-how and key brands (trademarks) in favor of its Russian partners.

  Read more

• Client Anvilab, LLC (Russia)

  Enforcement of patent rights through the agency of the Federal Antiminopoly Service

  Anvilab, LLC (Russia), being owner of a Eurasian patent to an invention “Anti-influenza agents” and also a manufacturer of medicine “AnviMax” discovered presence of “Angricaps Maxima”, a medicinal drug produced by UP Minskintercaps (Belarus) on the market.
  According to the results of conducted examination it was found that the invention described in the Eurasian patent was used in “Angricaps Maxima” drug. The patent owner did not give his consent to use the invention.

  Read more

• Client Catalytic People Limited (Cyprus)

  Licensing of unique software products and mobile applications

  Catalytic People Limited (Cyprus), being an affiliated company of OJSC Bank24.ru (Russia), has the exclusive rights to a large portfolio of solutions in the field of IT and mobile applications, which have been developed for the banking sector, and owns a variety of intellectual property subject matters, in particular, computer programs. With the aim of development of its software business and computer technologies Catalytic People Limited has decided to launch a smart licensing campaign over its key brands and software products in favor of third parties.

  Read more